Andrew Karolyi, dean of Cornell SC Johnson College of Business, was elevated to vice chair the PRME Advisory Board at the 2023 Global Forum. Today PRME launches a digital database of sustainability ...

Prime Medicine, Inc. (PRME) key stats comparison: compare with other stocks by metrics: valuation, growth, profitability, momentum, EPS revisions, dividends, ratings.

After reaching an important support level, Prime Medicine, Inc. (PRME) could be a good stock pick from a technical perspective. PRME recently experienced a "golden cross" event, which saw its 50-day ...

The recent orange, smoke-covered sky above New York City caused by Canadian wildfires was a stark reminder that business as usual is no longer an option. Growing sustainable businesses that not only ...

Prime Medicine, Inc.’s PRME shares have risen 16.4% in the past three months compared with the industry’s growth of 10.9%. The stock has also outperformed the sector and the S&P 500. The encouraging ...

We recently compiled a list of the Top 11 CRISPR Stocks to Invest In. In this article, we are going to take a look at where Prime Medicine, Inc. (NASDAQ:PRME) stands against the other CRISPR stocks.

Short interest in Prime Medicine Inc (NASDAQ:PRME) decreased during the last reporting period, falling from 19.25M to 19.12M. This put 17.63% of the company's publicly available shares short. Short ...

Shares of Prime Medicine, Inc. PRME were up 11.85% after the company announced a strategic research collaboration and license agreement with biotech giant Bristol Myers Squibb BMY. The collaboration ...

The United Nations’ Principles for Responsible Management Education (PRME) initiative brings together the UN and business schools around the world to “inspire and champion responsible management ...